A Baylor College of Medicine human RCT found GlyNAC supplementation improved 10 out of 13 hallmarks of aging in older adults. Here's what GlyNAC is, what the evidence actually shows, and how to dose it.
GlyNAC — a combination of glycine and N-acetylcysteine (NAC) — is one of the most compelling supplement stories in longevity research right now, not because of animal studies or theoretical mechanisms, but because of a peer-reviewed, placebo-controlled human randomized controlled trial that produced results that read almost too good to be true.
The study, published in *Clinical and Translational Medicine* in 2023 by Rajagopal Sekhar and colleagues at Baylor College of Medicine, enrolled 74 older adults (ages 71–80) and gave them either GlyNAC or placebo for 16 weeks. At the end of the trial, the GlyNAC group showed statistically significant improvements in 10 out of 13 predefined hallmarks of aging measured — including oxidative stress, mitochondrial function, inflammation, muscle strength, gait speed, cognitive tests, and endothelial function.
These are not soft surrogate markers. These are biologically meaningful outcomes that track closely with functional aging and all-cause mortality risk. The study didn't just move blood biomarkers — it moved performance measures.
GlyNAC is a combination of:
When combined, glycine and NAC address the two main bottlenecks in the glutathione synthesis pathway simultaneously. The result is a substantial increase in cellular glutathione — our primary endogenous antioxidant — which had declined by 50% or more in older adults compared to young controls in Sekhar's earlier studies.
The 2023 trial's key findings in older adults (vs placebo) after 16 weeks:
The glycine-only control arm (without NAC) did not show the same breadth of effects, confirming that the combination is necessary — glycine alone raises glutathione partially, but the synergy of the full GlyNAC combination appears critical.
This wasn't Sekhar's first GlyNAC study. His 2021 paper in *Journal of Nutrition* showed that older adults supplementing GlyNAC for 24 weeks corrected 11 defects compared to young healthy adults — essentially narrowing the biological gap between aged and young physiology on multiple measured parameters. That study was smaller and unblinded, but it established the biological plausibility framework that the 2023 RCT then tested in a rigorous design.
The Baylor studies used 1.33 mmol/kg/day of each component — which for an average 70 kg adult works out to roughly:
This is a substantially higher dose than most commercial GlyNAC supplements deliver. Most capsule products provide 1,000–2,000 mg combined, which is 10–20% of the trial dose. This means capsule-based products may not fully replicate what was used in the trial, though lower-dose products may still provide partial glutathione-supporting benefits.
Powder-based products — particularly pure glycine + NAC powder — allow dosing closer to the trial range at a fraction of the cost of capsules. If you're targeting the full Baylor-protocol dose, powders are the practical route.
GlyNAC is generally well tolerated. NAC at high doses can cause nausea, headache, and in rare cases, bronchospasm in asthmatic individuals. Starting with a lower dose and titrating up over 1–2 weeks reduces these effects. Glycine at very high doses (>20g/day) has caused drowsiness in some users due to its inhibitory neurotransmitter properties, though doses used in trials (8–10g) were not reported to cause this.
High-dose NAC combined with blood thinners (particularly warfarin) and nitroglycerin warrants physician oversight due to reported interactions.
What is GlyNAC and why is it getting attention?
GlyNAC is a combination of glycine and N-acetylcysteine, two amino acid derivatives that together boost cellular glutathione production — the body's primary antioxidant that declines dramatically with age. A 2023 randomized controlled trial at Baylor College of Medicine found GlyNAC significantly improved 10 of 13 measured hallmarks of aging in older adults over 16 weeks.
Can I just take separate glycine and NAC supplements instead of a GlyNAC product?
Yes — the Baylor studies used glycine and NAC separately, not a combined product. Buying them separately is typically more cost-effective and allows flexible dosing. The key is taking both together to achieve the glutathione-boosting synergy.
What dose of GlyNAC do I need?
The Baylor RCT dose was approximately 8–10g/day each of glycine and NAC for a 70 kg adult — higher than most capsule products deliver. For full trial-equivalent dosing, powder form is more practical and cost-effective.
How long before I notice results from GlyNAC?
The Baylor trials measured at 16–24 weeks. Measurable changes in blood markers (particularly oxidative stress markers) may be detectable earlier, but functional improvements like strength and gait speed took the full 16-week trial period.
Does GlyNAC interact with any medications?
NAC interacts with blood thinners (warfarin) and may potentiate the effects of nitroglycerin. High-dose NAC should be discussed with a physician if you're on anticoagulants. GlyNAC may also lower blood sugar slightly, warranting monitoring for diabetics.